Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Clover Health appoints new CFO for Medicare Advantage

Published 2024-03-07, 04:28 p/m
© Reuters.

FRANKLIN, Tenn. - Clover Health Investments, Corp. (NASDAQ: CLOV), a healthcare company specializing in Medicare Advantage, today announced the appointment of Clay Thornton as the new Chief Financial Officer of its Medicare Advantage division. Thornton brings over a decade of experience in healthcare financial management and operational leadership to Clover Health, where he will be instrumental in driving the company's PPO-first product strategy and pursuit of full-year Adjusted EBITDA profitability.

Thornton's previous roles include serving as Regional Chief Financial Officer and Vice President of Operations for Humana Inc (NYSE:HUM)., where he led a business generating $3 billion in revenue and oversaw significant Medicare Advantage membership growth. His recent experience in the venture capital and private equity sectors, providing advisory services to startups and small-to-mid-sized businesses, has further honed his strategic and operational skills.

"I am thrilled to join the team at Clover Health and drive forward their PPO-first approach in the Medicare Advantage space," Thornton stated. "Clover's innovative use of its proprietary Clover Assistant technology and advanced care management systems sets a new standard in managed care."

Andrew Toy, CEO of Clover Health, expressed confidence in Thornton's alignment with the company's mission and his ability to advance their technology-driven, patient-centered care model.

Clover Health is committed to improving healthcare access for Medicare recipients, focusing on health equity for seniors who have historically lacked affordable, high-quality healthcare options. The company is known for its Clover Assistant software platform, designed to support clinical decision-making and improve health outcomes by managing chronic disease.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.